Skip to main content
Download PDF

The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease

BMC Gastroenterology volume 24, Article number: 159 (2024) Cite this article

Abstract

Background

Obesity, cardiovascular diseases, and metabolic disorders are common problems among participants with non-alcoholic fatty liver disease (NAFLD). However, the association between these problems and the healthy eating index-2015 (HEI-2015) remains unknown. Although the HEI-2015 originated from American dietary guidelines, its comprehensive evaluation of diet quality provides valuable insights for various populations, including Iranians. Therefore, the objective of this study was to investigate the association between anthropometric, hepatic, and cardio-metabolic indices with HEI-2015 scores in participants with NAFLD.

Methods

We conducted a cross-sectional analysis of data from the Hoveyzeh Cohort Study, which included adults aged 35 to 70 years between 2016 and 2018. A total of 664 participant with NAFLD (452 females and 212 males) were included in the analysis. The HEI-2015 was assessed using the Food Frequency Questionnaire (FFQ). Various indices, including the body shape index (ABSI), atherogenic index of plasma (AIP), visceral adiposity index (VAI), lipid accumulation product (LAP), cardiometabolic index (CMI), lipoprotein combine index (LCI), AST/ALT ratio, ALD/NAFLD index, and hepatic steatosis index (HSI), were calculated.

Results

No significant differences were observed in anthropometric, cardio-metabolic, and hepatic indices across the quartiles of HEI-2015. However, among participants with NAFLD, men had significantly higher AIP and LCI levels, while women had significantly higher BMI, ABSI, VAI, LAP, and CMI levels. Additionally, women with NAFLD exhibited higher AST/ALT and HSI levels but lower ALD/NAFLD levels compared to men with NAFLD. Linear regression analysis among men with NAFLD revealed a significant negative correlation between HEI-2015 score and HSI in both the unadjusted model (β=-0.131, SE = 0.058, p = 0.024) and the adjusted model for energy intake (β=-0.129, SE = 0.058, p = 0.028).

Conclusion

The present study demonstrated a correlation between lower HEI-2015 scores and an increased risk of steatosis in men with NAFLD. Moreover, our findings highlighted gender-related differences in NAFLD and cardio-metabolic disorders.

Peer Review reports

Background

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver condition worldwide [1]. It encompasses a range of hepatic diseases that are associated with comorbidities such as dyslipidemia, hypertension, obesity, and type 2 diabetes mellitus [2]. The global prevalence of NAFLD is estimated to be approximately 25% [3]. The highest prevalence rates have been reported in South America and the Middle East (31% and 32% respectively), followed by Asia (27%), North America (24%), Europe (23%), and Africa (27%), according to studies [4]. The pathophysiology of NAFLD is multifactorial, involving various Factors such as genetic factors, insulin resistance, obesity, and dietary factors [5, 6]. The studies have demonstrated that obesity, particularly abdominal obesity, independently contributes to an increased risk of NAFLD [7]. NAFLD closely interacts with adipose tissue, which functions as an endocrine organ by secreting adipokines [8]. Adipokines are involved in several pathological conditions, including subclinical systemic inflammation, insulin resistance, dyslipidemia, and NAFLD [9]. Furthermore, NAFLD is strongly associated with metabolic syndrome, with approximately 91% of NAFLD participants presenting with at least one component of metabolic syndrome and about 57% have three or more criteria [10]. Additionally, NAFLD has been identified as an independent risk factor for cardiovascular disease and subclinical atherosclerosis [11]. Studies have reported higher 10-year cardiovascular risk scores in individuals with NAFLD compared to healthy subjects [12, 13].

Diet may play a mediating role in the relationship between NAFLD and cardiovascular and metabolic complications. The consumption of energy-dense, nutrient-poor snacks, cakes, biscuits, and soft drinks has been found to increase the risk of NAFLD [14]. Additionally, the role of specific macronutrients such as sugars and saturated fatty acids, as well as the Western dietary pattern characterized by highly processed foods, candies, sweets, sugar-sweetened beverages, refined grains, red meat, and high-fat dairy products, has been identified as crucial in the onset and progression of NAFLD [15]. Conversely, studies have shown that the consumption of omega-3 fatty acids, nuts, green coffee bean extract, dietary antioxidants, and adherence to Mediterranean dietary patterns can help prevent the progression of NAFLD [16,17,18,19,20].

Recent research suggests that assessing diet-disease associations using dietary quality indices is more informative than focusing on single nutrients or food items [21]. The Healthy Eating Index (HEI) was developed by the United States Department of Agriculture (USDA) as a tool to evaluate diet quality based on adherence to the 2015–2020 Dietary Guidelines for Americans [22]. Previous studies have indicated a correlation between lower HEI scores and an increased risk of various diseases [23,24,25]. Moreover, studies on the Iranian population have indicated a significant correlation between HEI and a reduced risk of NAFLD [26, 27]. However, the association between HEI scores and cardio-metabolic complications related to NAFLD in the Iranian population remains unknown. Therefore, the objective of this study was to investigate the relationship between obesity, hepatic and cardio-metabolic indices (as non-invasive markers), and HEI-2015 scores in participants with NAFLD.

Methods

Participants

The present cross-sectional study was conducted as part of the Hoveyzeh Cohort Study, a prospective population-based study focusing on non-communicable diseases in an Arab community in Southwest Iran [28]. The study included adults aged 35–70 years and was carried out between May 2016 and August 2018. Figure 1 illustrates that out of the 10,009 responders in Hoveyzeh city, a total of 675 participants with NAFLD were evaluated. The inclusion criteria for the study were the presence of NAFLD, willingness to participate, and age range of 35 to 70 years. We excluded 11 participants with NAFLD who did not meet the exclusion criteria: one with an energy intake of less than 800 kcal, two with an energy intake of more than 7000 kcal [29], and eight with alcohol consumption exceeding 2 g per day. Ultimately, the analysis was conducted on 664 participants with NAFLD, consisting of 452 females and 212 males.

Fig. 1
figure 1

Flow diagram of study selection

Full size image

Anthropometric assessment

Body weight was measured using a standing scale (Seca 755) in kilograms (kg), and height was measured using a stadiometer (Seca 206) in centimeters (cm). Waist circumference (WC), wrist circumference, and hip circumference (HC) were measured using Seca locked tape meters, also in centimeters (cm). The body mass index (BMI) was calculated by dividing the body weight (kg) by the square of height (meters, m). The Visceral Adiposity Index (VAI) and A Body Shape Index (ABSI) were calculated using the following formulas: [30, 31]

$$\text{A}\ \text{body}\ \text{shape}\ \text{index} \left(\text{ABSI}\right)=\frac{\text{WC}}{\text{BMI} 2/3\text{*heigh}1/2}$$

Visceral Adiposity Index (VAI):

$$\mathrm{Men}:\;\lbrack\mathrm{WC}/(39.68\:+\:1.88\;\times\;\mathrm{BMI})\rbrack\;\times\;(\mathrm{TG}\;(\mathrm{mmol}/\mathrm L)/1.03)\;\times\;(1.31/\mathrm{HDL}(\mathrm{mmol}/\mathrm L)$$
$$\mathrm{Women}:\;\lbrack\mathrm{WC}/(36.58\:+\:1.89\;\times\;\mathrm{BMI})\rbrack\;\times\;(\mathrm{TG}/0.81)\;\times\;(1.52/\mathrm{HDL})$$

HEI-2015 calculation

The dietary intake of participants with NAFLD over the past year was assessed using a Food Frequency Questionnaire (FFQ) consisting of 130 food items. The interviewer administered the FFQ and recorded the selected frequency category (day, week, month, or year) for each food item. The frequency categories were then converted to grams per day to estimate the intake of each food item. Nutrient intakes for all food items were calculated using the food ingredient table from the United States Department of Agriculture.

At the end of the study, three individuals who consumed less than 800 kcal or more than 7000 kcal per day were excluded from the analysis. A detailed description of the scoring criteria for the Healthy Eating Index-2015 (HEI-2015) has been provided elsewhere [32]. The HEI-2015 is based on thirteen components, including total fruits (0–5), whole fruits (0–5), total vegetables (0–5), greens and beans (0–5), whole grains (0–10), dairy (0–10), total protein foods (0–5), seafood and plant proteins (0–5), fatty acids (0–10), refined grains (0–10), sodium (0–10), added sugars (0–10), and saturated fats (0–10). The total HEI-2015 score is calculated by summing the scores of all thirteen components, ranging from 0 to 100.

Biochemical assessments

After a 12-hour overnight fast, a venous blood sample of 10 ml was collected from all participants. The blood samples were then centrifuged, and the resulting serums were stored at -70 °C until further analysis. Mean Corpuscular Volume (MCV) was measured using a hematology autoanalyzer (Nihon Kohden 6510-k, Japan). Serum levels of glucose, triglycerides (TG), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) were measured using a commercial kit (Pars Azmoon, Tehran, Iran). Serum low-density lipoprotein cholesterol (LDL) was calculated using the Friedewald Eq. [33]. Levels of Aspartate transaminase (AST), alanine aminotransferase (ALT), and Alkaline Phosphatase (ALP) were determined using the method recommended by the International Federation of Clinical Chemistry. All these analyses were performed using commercial kits (Pars Azmon Inc).

The atherogenic index of plasma (AIP), lipid accumulation product (LAP), cardiometabolic index (CMI), lipoprotein combine index (LCI), ALD/NAFLD Index, and hepatic steatosis index were calculated using the following formulas [34,35,36,37]:

$$\mathrm{Atherogenic}\;\mathrm{index}\;\mathrm{of}\;\mathrm{plasma}:\;\mathrm{Log}\;(\mathrm{TG}/\;\mathrm{HDL}-\mathrm C)$$
$$\mathrm{The}\;\mathrm{Lipid}\;\mathrm{Accumulation}\;\mathrm{Product}:\;\lbrack\mathrm{WC}-65\rbrack\;\times\;\lbrack\mathrm{TG}\rbrack\;\mathrm{in}\;\mathrm{men},\;\lbrack\mathrm{WC}-58\rbrack\;\times\;\lbrack\mathrm{TG}\rbrack\;\mathrm{in}\;\mathrm{women}$$
$$\mathrm{CMI};\;\mathrm{Cardiometabolic}\;\mathrm{index}:\;\mathrm{TG}/\mathrm{HDL}-\mathrm C\;\times\;(\mathrm{Waist}-\mathrm{to}-\mathrm{height})$$
$$\mathrm{The}\;\mathrm{lipoprotein}\;\mathrm{combine}\;\mathrm{index}:\;\mathrm{TC}\ast\mathrm{TG}\ast\mathrm{LDL}/\mathrm{HDL}-\mathrm C$$
$$\mathrm{ANI}:\;\mathrm{ALD}/\mathrm{NAFLD}\;\mathrm{Index}:\;-58.5\;+\;0.637\;(\mathrm{MCV})\;+\;3.91\;(\mathrm{AST}/\mathrm{ALT})\;-\;0.406\;(\mathrm{BMI})\;+\;6.35\;\mathrm{for}\;\mathrm{male}\;\mathrm{gender}$$
$$\mathrm{Hepatic}\;\mathrm{steatosis}\;\mathrm{index}:\;8\;\mathrm x\;(\mathrm{ALT}/\mathrm{AST}\;\mathrm{ratio})\;+\mathrm{BMI}\;(+2,\;\mathrm{if}\;\mathrm{female};\;+2,\;\mathrm{if}\;\mathrm{diabetes}\;\mathrm{mellitus})$$

To assess the presence of fatty liver, abdominal ultrasound scans were performed on the participants with confirmation from a gastroenterologist who was stationed at the cohort center. The ultrasound evaluations were conducted based on the participant’s medical history and in accordance with established protocols.

Statistical analysis

The data were analyzed using IBM SPSS Statistics software (Version 24) (IBM SPSS Statistics, Armonk, USA). The normality of variables was assessed using the Shapiro-Wilk test. HEI-2015 scores were divided into quartiles for analysis. ANOVA test for quantitative variables (parametric variables) and Kruskal-Wallis test for quantitative variables (non-parametric variables) were employed to compare continuous variables across quartiles of HEI-2015. The Chi-square test was used to compare categorical variables.

Linear regression analysis was conducted in three models to determine the association between the independent variable, HEI-2015 score, and the dependent variables, including anthropometric, metabolic, and hepatic indices. Model 0 represented linear regression analysis without any adjustment, Model 1 included adjustment for energy intake, and Model 2 involved adjustment for age, energy intake, and wrist circumference.

Binary logistic regression analysis was employed to explore the associations of HEI with anthropometric, metabolic, and hepatic indices. Based on previous studies, we considered BMI, ABSI, VAI, AIP, LAP, CMI, LCI, AST/ALT, ANI and HSI cut-off points to be 30, 0.08, 1.78, 0.11, 38, (0.8 for women, 1.748 for men), 16, 1, -0.66 and 36, respectively [38,39,40,41,42,43]. Values above these cut-off points were considered as the dependent variable in the study. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were reported for the association of HEI-2015 with metabolic and hepatic indices in both crude and adjusted models. Model 1 controlled for age, gender, and energy intake, while the second model further adjusted for education years, diabetes, smoking, and marital status. A p-value less than 0.05 was considered statistically significant.

Results

The characteristics of participants with NAFLD across the quartiles of HEI-2015 have been shown in Table 1. There were no significant differences observed in age, gender, smoking status, marital status, education level, diabetes, blood pressure, heart rate, anthropometric indices (weight, height, waist circumference, hip circumference), biochemical factors (fasting blood sugar, triglycerides, cholesterol, HDL, LDL, AST, ALT, ALP), and energy intake between the quartiles of HEI-2015 (p > 0.05). However, a significant difference was found in the levels of ALT among the groups (p = 0.04).

Table 1 Baseline characteristics of 664 participants with non-alcoholic fatty liver in a cross sectional study of Hoveyzeh Cohort Study
Full size table

The mean ± SD values of HEI-2015 and its components are presented in Table 2. The differences in the quartiles of HEI-2015 and its components were statistically significant (p < 0.05).

Table 2 A comparison between the quartiles of HEI-2015 and its components in participants with non-alcoholic fatty liver
Full size table

The comparison of anthropometric and metabolic indices based on quartiles of HEI-2015 is presented in Table 3. The results indicate that there were no significant differences in anthropometric indices (BMI, ABSI, VAI) and metabolic indices (AIP, LAP, CMI, LCI) according to quartiles of HEI-2015 (p > 0.05). Additionally, there were no significant differences in hepatic indices (AST/ALT, ALD/NAFLD index, hepatic steatosis index) based on quartiles of HEI-2015 (p > 0.05) (Table 4).

Table 3 A comparison between the anthropometric and cardiometabolic indices based on quartiles of HEI-2015
Full size table
Table 4 A comparison between the hepatic indices based on quartiles of HEI-2015
Full size table

The anthropometric indices levels including BMI (32.15 ± 5.46 vs. 30.62 ± 4.70, p < 0.001), ABSI (8.42 × 10 − 2 ± 0.005 vs. 8.13 × 10 − 2 ± 0.005, p < 0.001) and VAI (3.44 ± 2.62 vs. 3.14 ± 2.90, p = 0.184) were higher in women than men with NAFLD (Table 3).

The levels of metabolic indices, including AIP (0.26 ± 0.27 vs. 0.14 ± 0.26, p < 0.001) and LCI (27.56 ± 25.54 vs. 24.58 ± 26.31, p = 0.03), were significantly higher in men compared to women with NAFLD. On the other hand, women with NAFLD had higher levels of BMI (33.15 ± 5.46 vs. 30.62 ± 4.70), ABSI (8.13 × 10 − 2 ± 0.005 vs. 8.42 × 10 − 2 ± 0.005), VAI (3.44 ± 2.62 vs. 3.14 ± 2.90), LAP (103.28 ± 68.04 vs. 91.28 ± 61.76), and CMI (1.78 ± 1.16 vs. 1.50 ± 0.86) compared to men with NAFLD (Table 3). Furthermore, the comparison of hepatic indices revealed that women with NAFLD had higher AST/ALT (0.99 ± 0.37 vs. 0.73 ± 0.24, p < 0.001) and hepatic steatosis index (44.25 ± 6.06 vs. 42.93 ± 6.17, p = 0.01) levels, and lower ALD/NAFLD (-15.07 ± 5.04 vs. -7.71 ± 4.70, p < 0.001) index level compared to men with NAFLD (Table 4).

The comparison of anthropometric, metabolic, and hepatic indices based on quartiles of HEI-2015 is presented in Table 5. The linear regression analysis conducted among men with NAFLD revealed a significant negative correlation between HEI-2015 score and hepatic steatosis index in both the unadjusted model (B = -0.131, SE = 0.058, p = 0.024) and the adjusted model for energy intake (B = -0.129, SE = 0.058, p = 0.028) (Table 5). Additionally, BMI in men showed a positive correlation with HEI-2015 score in both the unadjusted model (B = 0.131, SE = 0.058, p = 0.028) and the adjusted model for energy intake (B = 0.142, SE = 0.058, p = 0.015). However, in terms of the association between HEI-2015 score as an independent variable and anthropometric, metabolic, and hepatic indices as dependent variables, there was no significant association observed in the unadjusted and adjusted models for other indices (p > 0.05) (Table 5).

Table 5 The Association between HEI-2015 score with anthropometric and metabolic indices in participants with non-alcoholic fatty liver
Full size table

The multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for HEI scores and cardio-metabolic and hepatic indices are presented in Table 6. The results showed no significant association between HEI score and the odds of cardio-metabolic and hepatic indices. However, after adjusting for age, gender, energy intake, education years, diabetes, smoking, and marital status, a significant positive association was found between HEI scores and BMI (OR: 1.198, 95% CIs: 1.031–1.392, p = 0.018) (Table 6).

Table 6 Odds ratios between healthy eating index and cardio-metabolic and hepatic indices in a cross sectional study of Hoveyzeh Cohort Study
Full size table

Discussion

In the present study, we investigated the association between HEI-2015 score and anthropometric, cardio-metabolic, and hepatic indices in participants with NAFLD in the Iranian population. Our findings revealed no significant differences in anthropometric, cardio-metabolic, and hepatic indices based on quartiles of HEI-2015. However, among men with NAFLD, we observed a significant inverse correlation between the total score of HEI-2015 and HSI, as well as a positive correlation with BMI.

Consistent with our findings, Yaoo et al. conducted a cohort study and reported that individuals with higher HEI-2015 scores, indicating better adherence to dietary recommendations, had a lower risk of NAFLD [44]. Similarly, Song-Yi et al. performed a nested case-control analysis and found an inverse association between higher HEI-2015 scores and NAFLD risk in a multiethnic population [45]. In a case-control study conducted by Hashemi Kani et al., it was observed that participants diagnosed with non-alcoholic fatty liver disease (NAFLD) had lower dietary quality scores based on the Healthy Eating Index (HEI) compared to their healthy counterparts [46].

The previous studies have consistently demonstrated the association between components of the HEI-2015 and the risk of NAFLD. Recent findings from a 4.2-year follow-up study in participants with NAFLD indicated that higher consumption of vegetables and fruits was associated with a protective effect against NAFLD and its associated metabolic comorbidities [36]. Furthermore, Bahrami et al. reported that a greater intake of legumes (OR = 0.73), lentils (OR = 0.61), and beans (OR = 0.35) was associated with a lower risk of NAFLD [47].

Moreover, a clinical trial demonstrated that a 12-week consumption of whole grains had beneficial effects on hepatic steatosis and the levels of alanine aminotransferase and aspartate aminotransferase in participants with NAFLD [44]. In terms of dairy consumption, a cross-sectional study reported that higher yogurt consumption (≥ 4 times/week) was associated with a lower odds ratio of newly diagnosed NAFLD compared to those who consumed yogurt less than once a week [48].

Furthermore, a clinical trial indicated that dietary intake of saturated fatty acids promotes fatty liver, while consumption of polyunsaturated fatty acids helps prevent liver fat accumulation and reduces hyperlipidemia in overweight subjects [49]. In our study, we observed that the severity of NAFLD, as assessed by hepatic indices such as HSI, ANI, and ALD/NAFLD, was worse in women compared to men. Conversely, cardio-metabolic indices such as AIP and LCI were more unfavorable in males with NAFLD compared to females. The results of studies evaluating the role of gender in the etiology of NAFLD and its cardio-metabolic outcomes are contradictory.

A cross-sectional analysis demonstrated that NAFLD had a greater adverse influence on lipid profiles in men than in women [50]. Another cross-sectional study by Ni et al. suggested that the effect of NAFLD on type 2 diabetes mellitus was more pronounced in males (OR = 2.442) than in females (OR = 1.814) [51]. However, contradicting our findings, a meta-analysis reported a higher prevalence of cardiovascular events in women with NAFLD compared to men [52].

In young people and before the onset of menopause in women, it seems that the risk of cardiovascular disease is more common in men than women, due to the fact that estrogen has a protective role against cardiovascular problems [53].

Since we did not evaluate menopausal status as a potential confounding factor in our study, it is recommended that future research should consider assessing the association between gender and NAFLD while taking menopausal status into account. A similar study considering menopausal status could provide further insights into the gender differences in NAFLD and its relationship with cardiovascular outcomes.

Limitations and future directions

A strength of the present study is large sample size, so that all the people of Hoveyzeh city were investigated. The present study had some limitations. First, FFQ to evaluate dietary intake is based on participants’ memories (which can cause both underestimation and overestimation), and it may introduce recall bias. Second, The HEI was developed by the United States Department of Agriculture and is based on dietary guidelines for Americans, so lack of HEI validation in the Iranian population is another limitation of this study.

Third, lack of histology data, confirmation of the data by histology could lead to a better interpretation of the results. Fourth, the absence of a comparator group comprising individuals without NAFLD. Incorporating this group would have enabled a more detailed analysis of the influence that dietary habits might have on the onset of NAFLD, thereby establishing a more distinct comparison between individuals with and without the condition.

Furthermore, in the current study, the limited range of clinical findings in participants with NAFLD may have limited our ability to thoroughly investigate the correlation between diet quality and hepatic indices in a wider range of NAFLD severity. Therefore, in order to have a more thorough understanding of how diet quality affects the advancement of NAFLD, future studies should encompass a broader spectrum of NAFLD stages.

Conclusions

The present study demonstrated a correlation between less healthy eating index score and increased risk of steatosis in men with NAFLD. Also, our finding indicated there was gender-related differences in NAFLD and cardio-metabolic problems. However, given some limitations in the present stuy, further research is needed to clarify the association between diet quality and cardio-metabolic complications related to NAFLD in the Iranian population .We also recommend studies with focus on gender as a decisive factor in NAFLD-related cardio-metabolic outcomes.

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Abbreviations

NAFLD:

Non-alcoholic fatty liver disease

ALD:

Alcoholic liver disease

HEI-2015:

Healthy eating index-2015

FFQ:

Food Frequency Questionnaire

ABSI:

A Body Shape Index

AIP:

Atherogenic index of plasma

VAI:

Visceral adiposity index

LAP:

Lipid accumulation product

CMI:

Cardiometabolic index

LCI:

Lipoprotein combine index

HIS:

Hepatic steatosis index

AST:

Aspartate aminotransferase

ALT:

Alanine transaminase

BMI:

Body mass index

MCV:

Mean Corpuscular Volume

TG:

Triglycerides

TC:

Total cholesterol

HDL-C:

High-density lipoprotein cholesterol

LDL:

Low-density lipoprotein cholesterol

LAP:

Lipid accumulation product

CMI:

Cardiometabolic index

LCI:

Lipoprotein combine index

WC:

Waist circumference

ANI:

Alcoholic liver disease /nonalcoholic fatty liver disease index

HSI:

Hepatic Steatosis Index

References

  1. Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2020;5:16.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jichitu A, Bungau S, Stanescu AMA, Vesa CM, Toma MM, Bustea C, et al. Non-alcoholic fatty liver disease and cardiovascular comorbidities: pathophysiological links, diagnosis, and therapeutic management. Diagnostics. 2021;11(4):689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.

    Article  PubMed  Google Scholar 

  4. Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672–82.

    Article  PubMed  Google Scholar 

  5. Yu J, Marsh S, Hu J, Feng W, Wu C. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterol Res Pract. 2016;2016:2862173.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kim H, Lee DS, An TH, Park H-J, Kim WK, Bae K-H, et al. Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC. Int J Mol Sci. 2021;22(9):4495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pang Q, Zhang J-Y, Song S-D, Qu K, Xu X-S, Liu S-S, et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterology: WJG. 2015;21(5):1650.

    Article  PubMed Central  Google Scholar 

  8. Boutari C, Perakakis N, Mantzoros CS. Association of adipokines with development and progression of nonalcoholic fatty liver disease. Endocrinol Metabolism. 2018;33(1):33–43.

    Article  CAS  Google Scholar 

  9. Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Paudel MS, Tiwari A, Mandal A, Shrestha B, Kafle P, Chaulagai B, Kc S. Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. Cureus. 2019;11(2):e4099.

  11. Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev Esp Enferm Dig. 2015;107(1):10–6.

    PubMed  Google Scholar 

  12. Cho YK, Kang YM, Yoo JH, Lee J, Lee SE, Yang DH, et al. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification. Sci Rep. 2018;8(1):12004.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Motamed N, Rabiee B, Poustchi H, Dehestani B, Hemasi GR, Khonsari MR, et al. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clin Res Hepatol Gastroenterol. 2017;41(1):31–8.

    Article  PubMed  Google Scholar 

  14. Yari Z, Cheraghpour M, Aghamohammadi V, Alipour M, Ghanei N, Hekmatdoost A. Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case–control study in Iran. BMC Res Notes. 2020;13(1):1–5.

    Google Scholar 

  15. Schattenberg JM, Bergheim I. Nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD). MDPI; 2019. p. 588.

    Google Scholar 

  16. Lee C-H, Fu Y, Yang S-J, Chi C-C. Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis. Nutrients. 2020;12(9):2769.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. He K, Li Y, Guo X, Zhong L, Tang S. Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br J Nutr. 2020;124(1):1–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Shahmohammadi HA, Hosseini SA, Hajiani E, Malehi AS, Alipour M. Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepat Monthly. 2017;17(4).

  19. Mahdavinia M, Alizadeh S, Vanani AR, Dehghani MA, Shirani M, Alipour M, et al. Effects of quercetin on bisphenol A-induced mitochondrial toxicity in rat liver. Iran J Basic Med Sci. 2019;22(5):499.

    PubMed  PubMed Central  Google Scholar 

  20. Suárez M, Boqué N, Del Bas JM, Mayneris-Perxachs J, Arola L, Caimari A. Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients. 2017;9(10):1052.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fardet A, Rock E. Toward a new philosophy of preventive nutrition: from a reductionist to a holistic paradigm to improve nutritional recommendations. Adv Nutr. 2014;5(4):430–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Guenther PM, Casavale KO, Reedy J, Kirkpatrick SI, Hiza HA, Kuczynski KJ, et al. Update of the healthy eating index: HEI-2010. J Acad Nutr Dietetics. 2013;113(4):569–80.

    Article  Google Scholar 

  23. Al-Ibrahim AA, Jackson RT. Healthy eating index versus alternate healthy index in relation to diabetes status and health markers in US adults: NHANES 2007–2010. Nutr J. 2019;18(1):1–18.

    Article  Google Scholar 

  24. Van Duong T, Tseng I-H, Wong T-C, Chen H-H, Chen T-H, Hsu Y-H, et al. Adaptation and validation of Alternative Healthy Eating Index in Hemodialysis patients (AHEI-HD) and its association with all-cause mortality: a multi-center follow-up study. Nutrients. 2019;11(6):1407.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ghanavati M, Behrooz M, Rashidkhani B, Ashtray-Larky D, Zameni SD, Alipour M. Healthy Eating Index in Patients With Cataract: A Case-Control Study. Iran Red Crescent Med J. 2015;17(10):e22490.

  26. Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver Disease (NAFLD). Hepat Mon. 2013;13(7):e10943.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Jahromi MK, Daftari G, Farhadnejad H, Tehrani AN, Teymoori F, Salehi-Sahlabadi A, et al. The association of healthy lifestyle score and risk of non-alcoholic fatty liver disease. BMC Public Health. 2023;23(1):973.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Cheraghian B, Hashemi SJ, Hosseini SA, Poustchi H, Rahimi Z, Sarvandian S, et al. Cohort profile: the Hoveyzeh Cohort Study (HCS): a prospective population-based study on non-communicable diseases in an arab community of Southwest Iran. Med J Islamic Repub Iran. 2020;34:141.

    Google Scholar 

  29. Shams-Rad S, Bidaki R, Nadjarzadeh A, Salehi-Abargouei A, de Courten B, Mirzaei M. The association between major dietary patterns and severe mental disorders symptoms among a large sample of adults living in central Iran: baseline data of YaHS-TAMYZ cohort study. BMC Public Health. 2022;22(1):1121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hosseini SA, Alipour M, Zakerkish M, Cheraghian B, Ghandil P. The Gene-Treatment Interaction of FTO-rs9939609 Gene Polymorphism and Epigallocatechin-GallateIntervention on Anthropometric Indices, Fasting Blood Sugar and insulin Resistance/Sensitivity in patients with type 2 diabetes Mellitus. Iran Red Crescent Med J. 2018;20(12):e82228.

    Google Scholar 

  31. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the healthy eating index: HEI-2015. J Acad Nutr Dietetics. 2018;118(9):1591–602.

    Article  Google Scholar 

  33. Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, et al. Validation of the Friedewald equation for evaluation of plasma LDL-cholesterol. J Clin Biochem Nutr. 2007;43(1):1–5.

    Article  PubMed Central  Google Scholar 

  34. Alipour M, Rostami H, Parastouei K. Association between inflammatory obesity phenotypes, FTO-rs9939609, and cardiovascular risk factors in patients with type 2 diabetes. J Res Med Sci. 2020;25:46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Abolnezhadian F, Hosseini SA, Alipour M, Zakerkish M, Cheraghian B, Ghandil P, Cheraghpour M. Association Metabolic Obesity Phenotypes with Cardiometabolic Index, Atherogenic Index of Plasma and Novel Anthropometric Indices: A Link of FTO-rs9939609 Polymorphism. Vasc Health Risk Manag. 2020;16:249–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Gómez-Álvarez E, Verdejo J, Ocampo S, Ponte-Negretti CI, Ruíz E, Ríos MM. The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: results from a real-world setting in Mexico. IJC Heart Vasculature. 2020;29:100545.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sviklāne L, Olmane E, Dzērve Z, Kupčs K, Pīrāgs V, Sokolovska J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol. 2018;33(1):270–6.

    Article  PubMed  Google Scholar 

  38. Zeinalabedini M, Nasli-Esfahani E, Esmaillzadeh A, Azadbakht L. How is healthy eating index-2015 related to risk factors for cardiovascular disease in patients with type 2 diabetes. Front Nutr. 2023;10:1201010.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Chen J, Mao X, Deng M, Luo G. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD. Eur J Gastroenterol Hepatol. 2022;10:1097.

    Google Scholar 

  40. Cerovic I, Mladenovic D, Ješic R, Naumovic T, Brankovic M, Vucevic D, et al. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2013;25(8):899–904.

    Article  CAS  PubMed  Google Scholar 

  41. Zou J, Xiong H, Zhang H, Hu C, Lu S, Zou Y. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population. BMC Gastroenterol. 2022;22(1):1–10.

    Article  Google Scholar 

  42. Si Y, Liu J, Han C, Wang R, Liu T, Sun L. The correlation of retinol-binding protein-4 and lipoprotein combine index with the prevalence and diagnosis of acute coronary syndrome. Heart Vessels. 2020;35:1494–501.

    Article  PubMed  Google Scholar 

  43. Hussain A, Gul MA, Khalid MU. Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan). BMJ Open Gastroenterol. 2019;6(1):e000316.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Yoo ER, Kim D, Vazquez-Montesino LM, Escober JA, Li AA, Tighe SP, et al. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality. Liver Int. 2020;40(4):815–24.

    Article  PubMed  Google Scholar 

  45. Park S-Y, Noureddin M, Boushey C, Wilkens LR, Setiawan VW. Diet quality association with nonalcoholic fatty liver disease by cirrhosis status: the multiethnic cohort. Curr Developments Nutr. 2020;4(3):nzaa024.

    Article  Google Scholar 

  46. Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). Hepat Mon. 2013;13(7):e10943.

  47. Kim S-A, Shin S. Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study. J Epidemiol Community Health. 2020;74(12):1035–42.

    PubMed  Google Scholar 

  48. Zhang S, Fu J, Zhang Q, Liu L, Lu M, Meng G, et al. Association between habitual yogurt consumption and newly diagnosed non-alcoholic fatty liver disease. Eur J Clin Nutr. 2020;74(3):491–9.

    Article  CAS  PubMed  Google Scholar 

  49. Rosqvist F, Kullberg J, Ståhlman M, Cedernaes J, Heurling K, Johansson H-E, et al. Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial. J Clin Endocrinol Metabolism. 2019;104(12):6207–19.

    Article  Google Scholar 

  50. Du T, Sun X, Yuan G, Zhou X, Lu H, Lin X, et al. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. Nutr Metabolism Cardiovasc Dis. 2017;27(1):63–9.

    Article  CAS  Google Scholar 

  51. Ni L, Yu D, Wu T, Jin F. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: an observational study. Medicine. 2021;100(6):e24743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Khalid YS, Dasu NR, Suga H, Dasu KN, Reja D, Shah A, et al. Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. Am J Cardiovasc Dis. 2020;10(3):258.

    PubMed  PubMed Central  Google Scholar 

  53. Hawksworth DJ, Burnett AL. Nonalcoholic fatty liver disease, male sexual dysfunction, and infertility: common links, common problems. Sex Med Reviews. 2020;8(2):274–85.

    Article  Google Scholar 

Download references

Acknowledgements

Authors wish to thank all participants who participated in this research project.

Funding

This study was financially approved by Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (HCS-9826).

Author information

Authors and Affiliations

  1. Nutrition and Metabolic Disease Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Seyed Ahmad Hosseini

  2. Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Ali Akbar Shayesteh & Seyed Jalal Hashemi

  3. Hearing Research Center, Clinical Sciences Research Institute, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Zahra Rahimi & Bahman Cheraghian

  4. Hearing Research Center, Clinical Sciences Research Institute, Department of Otolaryngology, Head and Neck Surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Nader Saki

  5. Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Hossein Bavi Behbahani

  6. Department of Nutrition, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran

    Meysam Alipour

Authors
  1. Seyed Ahmad Hosseini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Akbar Shayesteh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seyed Jalal Hashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zahra Rahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nader Saki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hossein Bavi Behbahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bahman Cheraghian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Meysam Alipour
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design: Ali Akbar Shayesteh and Seyed Jalal Hashemi; Acquisition of data: Bahman Cheraghian and Nader Saki; data analysis and interpretation, manuscript drafting and critical revision of the manuscript for important intellectual content: Meysam Alipour and Hossein Bavi Behbahani; statistical analysis: Zahra Rahimi; study supervision: Seyed Ahmad Hosseini. All authors read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Hossein Bavi Behbahani or Meysam Alipour.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Science (IR.AJUMS.REC.1398.642). Each participant signed the written informed consent. All methods were carried out in accordance with relevant guidelines and regulations (declaration of helsinki).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hosseini, S.A., Shayesteh, A.A., Hashemi, S.J. et al. The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease. BMC Gastroenterol 24, 159 (2024). https://doi.org/10.1186/s12876-024-03222-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12876-024-03222-x

Keywords

BMC Gastroenterology

ISSN: 1471-230X

Contact us